All In Biotech

Drug Trial Radar · NCT07262346

The Phase Ⅰd Clinical Trial of Hydronidone Capsules

Clinical Pharmacokinetic Study of Hydronione Capsules in Healthy Chinese Subjects (Ⅰd)

Last checked: Nov 19, 2026Latest source record: Sep 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 138 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

138

Actual

Start

Dec 24, 2025

Primary completion

May 28, 2026

Study completion May 28, 2026

Sponsor

Sponsor type
Industry
Collaborators
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
First posted
Dec 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Based on the Phase I (Ia, Ib, Ic) clinical pharmacokinetic study of Hydronidone Capsules, a clinical pharmacokinetic trial of Hydronidone Capsules (specification: 30 mg/capsule) was conducted, including single-dose administration, multiple-dose administration, and a food-effect study. The aim was to investigate the safety, tolerability, and pharmacokinetic characteristics of higher doses of Hydronidone Capsules (specification: 30 mg/capsule) in healthy subjects, in preparation for future expansion of indications.

Conditions

  • Liver Fibrosis

Interventions

  • Hydronidone capsulesDrug

    SAD:Single-dose administration MAD:Multiple-dose group Study on the Interaction between Food and Drugs

  • Placebo capsulesDrug

    SAD:Single-dose administration MAD:Multiple-dose group Study on the Interaction between Food and Drugs

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SAD :Blood drug PK parameters(Cmax)Time frame: 24 hours after administration
  2. SAD:Blood drug PK parameters(Tmax)Time frame: 24 hours after administration
  3. SAD:Blood drug PK parameters(AUC0-t)Time frame: 24 hours after administration
  4. SAD:Blood drug PK parameters( t1/2)Time frame: 24 hours after administration
  5. SAD:Blood drug PK parameters(AUC0-∞)Time frame: 24 hours after administration
  6. SAD:Blood drug PK parameters(λz)Time frame: 24 hours after administration
  7. SAD:Blood drug PK parameters(Vd/F)Time frame: 24 hours after administration
  8. SAD:Blood drug PK parameters(CL/F)Time frame: 24 hours after administration
  9. SAD:Blood drug PK parameters(AUC_%Extrap)Time frame: 24 hours after administration
  10. SAD:Blood drug PK parameters(MRT)Time frame: 24 hours after administration
  11. MAD:Blood drug PK parameters(ss)Time frame: 24 hours after administration
  12. MAD :Blood drug PK parameters(Cmax)Time frame: 24 hours after administration
  13. MAD:Blood drug PK parameters(Tmax)Time frame: 24 hours after administration
  14. MAD:Blood drug PK parameters(AUC0-t)Time frame: 24 hours after administration
  15. MAD:Blood drug PK parameters( t1/2)Time frame: 24 hours after administration
  16. MAD:Blood drug PK parameters(AUC0-∞)Time frame: 24 hours after administration
  17. MAD:Blood drug PK parameters(λz)Time frame: 24 hours after administration
  18. MAD:Blood drug PK parameters(Vd/F)Time frame: 24 hours after administration
  19. MAD:Blood drug PK parameters(CL/F)Time frame: 24 hours after administration
  20. MAD:Blood drug PK parameters(AUC_%Extrap)Time frame: 24 hours after administration
  21. MAD:Blood drug PK parameters(MRT)Time frame: 24 hours after administration
  22. The influence of food on the parameters of single-dose pharmacokinetics(Tlag)Time frame: 24 hours after administration
  23. The influence of food on the parameters of single-dose pharmacokinetics(Cmax)Time frame: 24 hours after administration
  24. The influence of food on the parameters of single-dose pharmacokinetics(Tmax)Time frame: 24 hours after administration
  25. The influence of food on the parameters of single-dose pharmacokinetics(AUC0-t)Time frame: 24 hours after administration
  26. The influence of food on the parameters of single-dose pharmacokinetics(AUC0-∞)Time frame: 24 hours after administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.